Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.
JTO Clinical and Research Reports|May 23, 2022
Implementing Lung Cancer Screening in Europe: Taking a Systems ApproachSuzanne Wait, Arturo Alvarez-Rosete, Tasnime Osama, et al.
Blood|September 5, 2008
Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigensArancha Rodríguez-Caballero, Andrés C García-Montero, Paloma Bárcena, et al.
The Oncologist|December 26, 2022
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint InhibitorsFabrice Barlesi, Nicolas Isambert, Enriqueta Felip, et al.
Clinical Lung Cancer|December 3, 2016
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by SurgeryMariacarmela Santarpia, Jose Luis Ramirez, Itziar de Aguirre, et al.
BMC Psychology|November 24, 2020
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal studyN Nuria Viñolas, Rosario Garcia-Campelo, Margarita Majem, et al.
Journal of Cardiothoracic Surgery|April 12, 2007
Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control studyJuan J Jimenez Rivera, Jose L Iribarren, Jose M Raya, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumNuria Viñolas, Laura Mezquita, Jesús Corral, et al.
Future Oncology (London, England)|March 2, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study designPilar Garrido, Jean-Louis Pujol, Edward S Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2021
Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohortVictor Moreno, Pilar Garrido, Kyriakos P Papadopoulos, et al.
Pageof 17